- News Home
5 December 2013 11:26 am ,
Vol. 342 ,
An animal rights group known as the Nonhuman Rights Project filed lawsuits in three New York courts this week in an...
Researchers have been hot on the trail of the elusive Denisovans, a type of ancient human known only by their DNA and...
Thousands of scientists in the Russian Academy of Sciences (RAS) are about to lose their jobs as a result of the...
Dyslexia, a learning disability that hinders reading, hasn't been associated with deficits in vision, hearing, or...
Exotic, elusive, and dangerous, snakes have fascinated humankind for millennia. They can be hard to find, yet their...
Researchers have sequenced and analyzed the first two snake genomes, which represent two evolutionary extremes. The...
Snake venoms are remarkably complex mixtures that can stun or kill prey within minutes. But more and more researchers...
At age 30, Dutch biologist Freek Vonk has built up a respectable career as a snake scientist. But in his home country,...
- 5 December 2013 11:26 am , Vol. 342 , #6163
- About Us
Italian Virus Outbreak May Portend Global Spread
7 September 2007 (All day)
Another pathogen has jumped its traditional boundaries to begin what some fear is a march around the globe. This time the invader is a virus that causes chikungunya, a crippling and painful disease until now found only in the tropics. This summer, it sickened more than 160 people in and around two small villages in Italy. Chikungunya is transmitted by the Asian tiger mosquito (Aedes albopictus), a species that is taking the world by storm, and medical entomologists worry that the disease has the potential to follow the insect.
Chikungunya is rarely fatal but can cause severe fevers, headaches, fatigue, nausea, and muscle and joint pains. People started falling sick in Castiglione di Cervia and Castiglione di Ravenna--two small villages separated by a river in the province of Ravenna--in early July, says Antonio Cassone of the Istituto Superiore di Sanità (ISS), a national government lab in Rome. But because symptoms overlap with those of other diseases, such as the Toscana virus, it took a long time to get noticed, he says. Samples reached ISS on 27 August, and the virus was identified the next day.
Epidemiological detective work suggests that the index patient was a man who traveled to one of the villages and fell sick there, after having been infected in India. Isolation and sequencing of the virus is under way to confirm that theory, Cassone says. One patient, an 83-year-old man with severe previous medical problems, has died; more than 30 cases are still awaiting lab confirmation.
Chikungunya caused a massive outbreak at La Réunion, a French island in the Indian Ocean, as well as several nearby islands, in 2005 and 2006. (ScienceNOW, 17 February 2006). India, too, has been hit very hard in recent years. Several European countries had seen "imported" cases of chikungunya lately--that is, people who were infected elsewhere. But local transmission in Europe has never been observed before. "It's fascinating," says entomologist Paul Reiter of the Pasteur Institute in Paris, France.
It's too early to tell whether the virus now has a permanent foothold in Europe. New cases have slowed down to a trickle, says Cassone, in part because the mosquito population is dwindling. But the critical question is whether infected mosquitoes can survive the winter or pass on the virus to their offspring via their eggs, says Reiter. "If they can, we might see a rip-roaring epidemic next year," he says.
There are neither drugs nor vaccines against chikungunya, but the outbreak at La Réunion has triggered renewed interest in an old vaccine candidate developed in the 1980s by a U.S. Army lab in Fort Detrick, Maryland, that was later shelved. Scientists at three French government institutions are currently working on that vaccine, and new clinical trials might begin before the end of 2008, says epidemiologist Antoine Flahault, who chaired a French task force on chikungunya last year.